Revolution Medicines, Inc. (RVMDW) stock
RVMDWNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as RVMD
$9.81+0.18 (+1.82%)
Close on Oct 30, 2026Market cap $41.00BP/E –Yield –
Revolution Medicines price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Revolution Medicines's price to sales ratio was 458.3× on Mar 28, 2024, against 55.4× a year earlier. Over the last 4 years it ranged from 1.4× to 458.3×, with a median of 56.9×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2024 | Mar 28, 2024 | 458.3× | +338.4 |
| 2023 | Dec 29, 2023 | 120.0× | +49.1 |
| 2022 | Dec 30, 2022 | 70.9× | +6.2 |
| 2021 | Dec 31, 2021 | 64.6× | +8.0 |
| 2020 | Dec 31, 2020 | 56.7× | – |